Codes / ICD10CM / L49.4

L49.4 Exfoliation due to erythematous condition involving 40-49 percent of body surface

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Exfoliation due to erythematous condition involving 40-49 percent of body surface

Summary

Exfoliation due to erythematous conditions is a skin disorder characterized by the shedding or peeling of the outer skin layer, associated with underlying redness and inflammation. This condition involves 40-49 percent of the body surface and may result from multiple causes, including allergic reactions, autoimmune disorders, or infections.

Causes

Exfoliation due to erythematous conditions can be triggered by various factors, such as allergic reactions to medications or topical products, autoimmune diseases, skin infections, or environmental irritants. The underlying erythematous condition drives the exfoliative process.

Risk Factors

Risk factors include a personal or family history of skin allergies, pre-existing dermatologic conditions like eczema or psoriasis, exposure to harsh chemicals, and the use of new or irritating skin care products. Immunosuppression or recent infections may also increase susceptibility.

Symptoms

Symptoms typically include redness and inflammation of the skin, peeling or scaling, itching or discomfort, and mild swelling or sensitivity in affected areas. The severity and distribution depend on the underlying cause and extent of body surface involvement.

Diagnosis

Diagnosis is based on a physical examination of the skin, review of patient history, and assessment of the extent of body surface involvement. In some cases, skin biopsy or blood tests may be conducted to identify underlying causes.

Treatment Options

Treatment focuses on addressing the underlying cause and providing symptomatic relief. Options may include topical or systemic corticosteroids to reduce inflammation, moisturizers to hydrate the skin, antihistamines for itching, and avoidance of known irritants or allergens.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and response to treatment. Regular follow-up is important to monitor skin healing, manage symptoms, and adjust therapy as needed. Long-term management may be required for chronic or recurrent cases.

Complications

Potential complications include secondary skin infections, fluid loss due to extensive exfoliation, and discomfort or pain. Severe cases may require hospitalization for supportive care.

Lifestyle & Prevention

Maintain gentle skin care routines, avoid harsh chemicals or irritants, and use moisturizers to protect the skin. Promptly address any new skin reactions or exposures to reduce the risk of worsening exfoliation.

When to Seek Professional Help

Seek medical attention if symptoms worsen, spread, or are accompanied by fever, pain, or signs of infection. Immediate care is recommended for extensive skin involvement or systemic symptoms.

Tips for Medical Coders

Document the extent of body surface involvement (40-49 percent) and any underlying erythematous condition. Ensure clinical notes support the diagnosis and specify the percentage of body surface affected to justify code assignment.

Book a walkthrough

L49.4 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.